Thursday, April 23rd, 2015 - General News
CONTINUUS Pharmaceuticals was selected to present its technology at the 2015 BIO International Convention in Philadelphia during June 15-18. CONTINUUS will showcase its work at the NSF/NIH Bio Innovation Zone, which has been funded by a Phase I SBIR grant from the NSF. CONTINUUS was also one of twelve companies chosen to present/pitch their stories, pipelines, and objectives to all attendees.
Comments